Literature DB >> 19951966

Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm.

Chung-Wah Siu1, Timothy Watson, Wing-Hon Lai, Yee-Ki Lee, Yap-Hang Chan, Kwong-Man Ng, Chu-Pak Lau, Gregory Y H Lip, Hung-Fat Tse.   

Abstract

AIMS: To determine whether the number of circulating endothelial progenitor cells (EPCs) in patients with persistent atrial fibrillation (AF) predicts arrhythmia recurrence after direct current cardioversion (DCCV). METHODS AND
RESULTS: The numbers of circulating CD34+/KDR+ EPCs were determined with flow cytometry in 51 consecutive patients with persistent AF [the mean age: 67 +/- 1.3 years, male (65%)] prior to DCCV and were compared with that of age- and sex-matched controls, and cohorts of patients with coronary artery disease and ischaemic stroke. The AF recurrence rate at 1 year was also determined. The EPCs in patients with persistent AF, patients with coronary artery disease, and patients with ischaemic stroke were significantly lower than that of the age- and sex-matched controls (P < 0.01). One year after successful DCCV, patients with high EPC count (50th to 100th percentile) had a higher recurrence rate of AF when compared with those with low EPC count (less than 50th percentile) (73 vs. 40%, P = 0.02). Cox regression analysis revealed the high EPC count was the only independent predictors for the AF recurrence (HR: 2.29, P = 0.047).
CONCLUSION: The number of EPCs is reduced in patients with persistent AF and predicts the recurrence of AF after successful DCCV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19951966     DOI: 10.1093/europace/eup382

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  2 in total

1.  Atrial fibrillation is associated with hematopoietic tissue activation and arterial inflammation.

Authors:  Philip Joseph; Amorina Ishai; Megan MacNabb; Amr Abdelbaky; Zachary R Lavender; Jeremy Ruskin; Matthias Nahrendorf; Ahmed Tawakol
Journal:  Int J Cardiovasc Imaging       Date:  2015-09-28       Impact factor: 2.357

2.  Fluvastatin therapy could not decrease progression of paroxysmal atrial fibrillation in non-valvular disease patients.

Authors:  Qiang Tan; Shuangyue Zhang; Xiaoyi Zou; Jun Zhao; Jia Hao; Qian Sun
Journal:  Anatol J Cardiol       Date:  2017-04-10       Impact factor: 1.596

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.